BDC-3042

· Bolt Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BDC-3042, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies [Phase 1]

See pricing